The pathophysiological importance of understanding how phosphorylation affects activity is highlighted by the observation that cardiac myosin binding protein-C (cMyBP-C) is one of the two most prevalent locations for mutations associated with hypertrophic cardiomyopathy (HCM) (Konno et al., 2010). The gene discussed is MYBPC3; the disease is hypertrophic cardiomyopathy.